Bayer Voluntarily Recalls Larotrectinib In US Due To Microbial Contamination Observed During Routine Stability Testing
November 20, 2023
Reuters (11/17, Satija) reported, “Bayer said on Friday it was voluntarily recalling one lot of its cancer drug Vitrakvi [larotrectinib] in the U.S. due to the presence of microbial contamination that was observed during routine stability testing.” The dr...